The importance of global surveillance of cancer survival for cancer control: The concord programme
CONCORD is a prize-winningi programme for the global surveillance of cancer survival. It started in 1999, with the aim of monitoring
Read MoreSelect Page
Posted by Cancer Control | 2017-3
CONCORD is a prize-winningi programme for the global surveillance of cancer survival. It started in 1999, with the aim of monitoring
Read MorePosted by Cancer Control | 2017-2
The Access to Medicine Index has been analyzing 20 of the largest R&D-based pharmaceutical companies by revenue on how…
Read MorePosted by Cancer Control | 2017-1
In May 2017, the cancer community celebrated a landmark achievement with the adoption of a new resolution on cancer, providing a health systems response to cancer
Read MorePosted by Cancer Control | 2019-4
Professor Nausherwan K Burki writes: A first-hand account of establishing a tertiary care cancer hospital in Pakistan…
Read MorePosted by Cancer Control | 2019-3
The Cancer Screening in Five Continents project (CanScreen5) of the International Agency for Research on Cancer (IARC) is designed to uniformly collect, analyse, store and disseminate…
Read More